Trials / Completed
CompletedNCT01560832
Descriptive Epidemiology of Clostridium Difficile Infection in Hospitalized Adult Patients in the Asia Pacific Region
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 188 (actual)
- Sponsor
- Yonsei University · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
Clostridium difficile is an important pathogen, causing disease that ranges from mild self-limited diarrhea to life-threatening pseudomembranous colitis. It is estimated that C. difficile is responsible for 10% to 25% of all cases of antibiotic-associated diarrhea and for almost all cases of pseudomembranous colitis. C. difficile disease is mediated by two large toxins, A and B. The toxins damage intestinal epithelial cells and cause the clinical illness. Primary risk factors for C. difficile clinically apparent infection include antimicrobial therapy, hospitalization, residence in a long-term care facility, older age (≥ 65 years), and increased length of hospital stay. The incidence of CDI both in the hospital and the community is important in the understanding and characterization of the disease and its prevention. This observational, epidemiological study will advance the investigators understanding of CDI risk factors in several hospitals and possibly the community in the Asia Pacific region.
Conditions
Timeline
- Start date
- 2011-12-01
- Primary completion
- 2012-06-01
- Completion
- 2012-06-01
- First posted
- 2012-03-22
- Last updated
- 2014-03-05
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01560832. Inclusion in this directory is not an endorsement.